Establishing Content Validity of Three New Patient Reported Outcome (PRO) Measures for Use in HIV Long-Acting Oral Antiretroviral Therapy (LA-OART) Clinical Trials

Author(s)

Bailey JR1, Javidnia P1, Fonseca E2, Borsa A1, Hawryluk E1, Gubernick SI1, de la Motte A1, Karantzoulis S1, Reaney M3, Saretsky TL2
1IQVIA, New York, NY, USA, 2Merck & Co., Inc., Rahway, NJ, USA, 3IQVIA, Reading, UK

OBJECTIVES: Long-acting oral antiretroviral therapy (LA-OART) is in development for people living with HIV (PLWH). This study aimed to demonstrate content validity of patient reported outcome (PRO) measures for use within LA-OART clinical trials. Previously, a targeted literature review and concept elicitation interviews with clinicians and PLWH were conducted to develop conceptual models (CMs) capturing PLWH experiences of OART, adherence facilitators and barriers, and perspectives on a hypothetical switch to LA-OART. Herein we describe cognitive debriefing (CD) interviews to ensure relevance and understandability of these PRO measures.

METHODS: CMs were discussed, concepts were prioritized during an Item Generation Meeting with PRO and clinical experts, and concepts were drafted into measures in paper and electronic formats, following FDA PRO development guidance. Recruitment followed an inclusive sampling strategy, aiming for adequate representation of the PLWH population. Interviews were completed across 3 waves (10 PLWH per wave; 5 debriefing paper, 5 electronic).

RESULTS: Three measures were drafted: the HIV Patient Perspective of Regimen (HIV-PP-R), which explores perceptions of the trial OART; the HIV Patient Perspective of Regimen Change (HIV-PP-RC), which explores perceptions of the trial OART versus the pre-trial OART; and the HIV Drivers of Adherence Questionnaire (HIV-DAQ), which explores OART-taking behavior and reasons for this behavior during the trial. Thirty PLWH (aged 22-64 years) participated in CD, including 63% men who have sex with men, 7% transgender women, 7% people who inject drugs and 33% heterosexual men or women. Participants perceived all 3 measures as assessing relevant and important concepts. Measures were refined following each wave. Understandability was confirmed in wave 3. The final HIV-PP-R and HIV-PP-RC contained 10 items each. The final HIV-DAQ contained 22 items.

CONCLUSIONS: CD findings support content validity of the 3 measures. With these measures, LA-OART trials may better assess adherence attributes of and considerations in switching to LA-OART among PLWH.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

PCR253

Topic

Patient-Centered Research

Topic Subcategory

Instrument Development, Validation, & Translation, Patient-reported Outcomes & Quality of Life Outcomes

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×